HIV mutation literature information.


  Geographic and temporal trends in the molecular epidemiology and genetic mechanisms of transmitted HIV-1 drug resistance: an individual-patient- and sequence-level meta-analysis.
 PMID: 25849352       2015       PLoS medicine
Method: Thymidine-analog mutations (TAMs) were defined as the NRTI SDRMs M41L, D67N/G/E, K70R, L210W, T215Y/F/S/C/D/E/I/V, and K219Q/E/N/R.


  Global HIV-1 transmitted drug resistance in the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial.
 PMID: 25711326       2015       HIV medicine
Abstract: The most frequent TDR mutations observed were M41L, D67N/G/E, T215F/Y/I/S/C/D/E/V/N, 219Q/E/N/R, K103N/S, and G190A/S/E in reverse transcriptase, and M46I/L and L90M in protease.


  Early clinical response and presence of viral resistant minority variants: a proof of concept study.
 PMID: 25397504       2014       Journal of the International AIDS Society
Abstract: One patient without baseline resistance selected for M184I+E138K+T215I (NGS) after four months of TDF/FTC/RPV therapy.
Abstract: Single mutations E138K (two cases) and M184V in three distinct patients and V90I+G190E; M184V+A98S; Y215F+V118I+T215I; L210S+T215I+F227L; and A62V+D67G+K70N+188H in the remaining five subjects.


  Virological failure and HIV-1 drug resistance mutations among naive and antiretroviral pre-treated patients entering the ESTHER program of Calmette Hospital in Cambodia.
 PMID: 25166019       2014       PloS one
Result: The TAM1 pathway was present mostly in pre-treated patients (M41L 4/15, 27.7%; L210W: 3/15, 20%, T215Y/I/Y: 6/15, 40%).


  Oligonucleotide ligation assay detects HIV drug resistance associated with virologic failure among antiretroviral-naive adults in Kenya.
 PMID: 25140907       2014       Journal of acquired immune deficiency syndromes (1999)
5Result: Consensus sequencing confirmed baseline mutations in 6 of the 7 participants identified by OLA, and detected baseline mutations at sites associated with ""potential low-level resistance"" to didanosine and abacavir or ""low-level resistance"" to zidovudine and stavudine in 4 additional participants at codons not evaluated by OLA (T215T/I, n=1; T69S, n=1; T69T/N, n=2) (hivdb.stanford.edu)."


  2014 Update of the drug resistance mutations in HIV-1.
 PMID: 25101529       2014       Topics in antiviral medicine
Discussion: The T215A/C/D/E/G/H/I/L/N/S/V substitutions are revertant mutations at codon 215 that confer increased risk of virologic failure of zidovudine or stavudine in antiretroviralnaive patients.


  A simian-human immunodeficiency virus carrying the rt gene from Chinese CRF01_AE strain of HIV is sensitive to nucleoside reverse transcriptase inhibitors and has a highly genetic stability in vivo.
 PMID: 24709063       2014       Microbes and infection
Abstract: The rt gene of RT-SHIV/AE lacked the common mutation (T215I) associated with drug resistance.


  Incidence of transmitted antiretroviral drug resistance in treatment-naive HIV-1-infected persons in a large South Central United States clinic.
 PMID: 24473489       2014       The Annals of pharmacotherapy
Abstract: The L90M mutation was the most frequently observed PI SDRM (1.6%), while the T215C/D/I mutation was the most common NRTI SDRM identified (1.9%).


  Effectiveness of first-line antiretroviral therapy and correlates of longitudinal changes in CD4 and viral load among HIV-infected children in Ghana.
 PMID: 24119088       2013       BMC infectious diseases
Table: T215F/I


  Transmission patterns of HIV-subtypes A/AE versus B: inferring risk-behavior trends and treatment-efficacy limitations from viral genotypic data obtained prior to and during antiretroviral therapy.
 PMID: 23469241       2013       PloS one
Table: T215I



Browser Board

 Co-occurred Entities




   Filtrator